Treatment of Candida famata bloodstream infections: case series and review of the literature

Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia

(2012) Dhara N. Shah et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes

(2011) D. N. Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Yeast from burn patients at a major burn centre of China

(2010) Gaoxing Luo et al.   BURNS

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome

(2009) C.Y. Liu et al.   JOURNAL OF INFECTION

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Debaryomyces hansenii (Candida famata), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii (Candida guilliermondii)

(2008) M. Desnos-Ollivier et al.   JOURNAL OF CLINICAL MICROBIOLOGY